Why did AFME.PA stock move sharply intraday today?

AFME.PA stock rose on heavy volume and momentum trading. There was no confirmed earnings release linked to the spike. Market flows and small-cap device sector interest drove the move, according to intraday volume and technical indicators.

What are the key valuation ratios for AFME.PA stock?

Key metrics: EPS **-€0.36**, PE **-7.81**, price-to-sales **23.52**, price-to-book **5.24**, debt-to-equity **1.11**, current ratio **1.07**. These ratios reflect loss-making status and stretched valuation.

What does Meyka AI forecast for AFME.PA stock?

Meyka AI's forecast model projects **€3.60** monthly and **€1.71** yearly. That implies about **-2.70%** short-term and **-53.87%** one-year downside versus **€3.70**. Forecasts are model projections, not guarantees.

What are the main risks for AFME.PA stock holders?

Main risks include negative earnings, long receivables days (**325.12**), modest cash per share (**€0.14**), and leverage. Regulatory or clinical setbacks could trigger further downside for this device company.

EU Stocks

+31.67% AFME.PA Affluent Medical Euronext 25 Feb 2026: volume surge

ByDanny Kontos February 25, 2026February 25, 2026

The AFME.PA stock surged +31.67% intraday to €3.70 on Euronext on 25 Feb 2026 on a clear volume spike. Trading volume hit 27,635 shares versus an average of 27,900, lifting the share price above its previous year high of €2.95. This intraday move marks a sharp change in market interest for Affluent Medical SA and puts the stock in the high-volume movers category for Europe. We track the price action, fundamentals, technicals, and our model-driven outlook to explain the move and next triggers.